BR112014008464A2 - composto; composição farmacêutica; método para ligar dna de fita dupla com especificidade para sequência; método para reduzir ou inibir a proliferação de células de papiloma ou neoplásticas; método para tratar células infectadas por vírus; e método para tratar hpv em um indivíduo - Google Patents

composto; composição farmacêutica; método para ligar dna de fita dupla com especificidade para sequência; método para reduzir ou inibir a proliferação de células de papiloma ou neoplásticas; método para tratar células infectadas por vírus; e método para tratar hpv em um indivíduo

Info

Publication number
BR112014008464A2
BR112014008464A2 BR112014008464A BR112014008464A BR112014008464A2 BR 112014008464 A2 BR112014008464 A2 BR 112014008464A2 BR 112014008464 A BR112014008464 A BR 112014008464A BR 112014008464 A BR112014008464 A BR 112014008464A BR 112014008464 A2 BR112014008464 A2 BR 112014008464A2
Authority
BR
Brazil
Prior art keywords
treating
papilloma
proliferation
inhibiting
individual
Prior art date
Application number
BR112014008464A
Other languages
English (en)
Inventor
Fisher Christopher
D Harris George Jr
K Bashkin James
J Koeller Kevin
G Edwards Terri
Original Assignee
Nanovir Llc
Univ Missouri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanovir Llc, Univ Missouri filed Critical Nanovir Llc
Publication of BR112014008464A2 publication Critical patent/BR112014008464A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

resumo composto; composição farmacêutica; método para ligar dna de fita dupla com especificidade para sequência; método para reduzir ou inibir a proliferação de células de papiloma ou neoplásticas; método para tratar células infectadas por vírus; e método para tratar hpv em um indivíduo trata-se de composições de poliamida que contêm radicais de guanidinila, incluindo radicais de tetrametilguanidinila. essas poliamidas são úteis para aplicações médicas, por exemplo, para tratar infecções por vírus do papiloma humano. 1/1
BR112014008464A 2011-10-10 2012-10-10 composto; composição farmacêutica; método para ligar dna de fita dupla com especificidade para sequência; método para reduzir ou inibir a proliferação de células de papiloma ou neoplásticas; método para tratar células infectadas por vírus; e método para tratar hpv em um indivíduo BR112014008464A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161545311P 2011-10-10 2011-10-10
PCT/US2012/059604 WO2013055825A2 (en) 2011-10-10 2012-10-10 Guanidinyl-substituted polyamides useful for treating human papilloma virus

Publications (1)

Publication Number Publication Date
BR112014008464A2 true BR112014008464A2 (pt) 2017-04-11

Family

ID=48042465

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014008464A BR112014008464A2 (pt) 2011-10-10 2012-10-10 composto; composição farmacêutica; método para ligar dna de fita dupla com especificidade para sequência; método para reduzir ou inibir a proliferação de células de papiloma ou neoplásticas; método para tratar células infectadas por vírus; e método para tratar hpv em um indivíduo

Country Status (12)

Country Link
US (1) US9133228B2 (pt)
EP (1) EP2751096A4 (pt)
JP (1) JP2015502330A (pt)
KR (1) KR20140074996A (pt)
CN (1) CN104024247B (pt)
AU (1) AU2012322835A1 (pt)
BR (1) BR112014008464A2 (pt)
CA (1) CA2851516C (pt)
HK (1) HK1201064A1 (pt)
RU (1) RU2014113702A (pt)
SG (1) SG11201401226YA (pt)
WO (1) WO2013055825A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9982020B2 (en) * 2011-10-10 2018-05-29 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses
WO2016022664A1 (en) 2014-08-05 2016-02-11 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded dna viruses

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7380294A (en) 1993-08-06 1995-02-28 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents
WO1998037066A1 (en) 1996-02-26 1998-08-27 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded dna
CN1260006A (zh) 1996-02-26 2000-07-12 加利福尼亚州技术学院 双链dna和杂环低聚物之间复合物的形成
AU6255298A (en) 1996-02-26 1998-09-09 California Institute Of Technology Design, synthesis and use of specific polyamide dna-binding ligands
US5998140A (en) 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
WO1998035702A1 (en) 1996-08-01 1998-08-20 California Institute Of Technology Inhibition of gene transcription by polyamide dna-binding ligands
JP2003505521A (ja) 1998-09-11 2003-02-12 カリフォルニア・インスティテュート・オブ・テクノロジー 合成ポリアミドによる癌遺伝子転写の阻害
US6673940B1 (en) 1999-01-08 2004-01-06 California Institute Of Technology Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
WO2003000683A1 (en) 2001-06-25 2003-01-03 Japan Science And Technology Agency Method of the solid phase synhesis of pyrrole-imidazole polyamide
JP2005508181A (ja) 2001-11-07 2005-03-31 ファルマシア・コーポレーション Ｃｏｘ２転写のポリアミド調節因子
AU2002363523A1 (en) 2001-11-07 2003-05-19 Pharmacia Corporation Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
EP1585571B1 (en) 2003-01-16 2010-05-19 Femmepharma Holding Cpmpany, Inc. Vaginal or rectal applicator and method
US8524899B2 (en) 2003-03-04 2013-09-03 California Institute Of Technology Alternative heterocycles for DNA recognition
US20050009054A1 (en) 2003-04-30 2005-01-13 Pharmacia Corporation Compounds having a fused, bicyclic moiety for binding to the minor groove of dsDNA
US8399013B2 (en) 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
WO2005033282A2 (en) * 2003-10-01 2005-04-14 Pharmacia & Upjohn Company Llc Polyamide compositions and therapeutic methods for treatment of human papilloma virus
DE10357677A1 (de) 2003-12-10 2005-07-14 Greiner Bio-One Gmbh Primer und Sonden zum Nachweis genitaler HPV-Genotypen
WO2007045096A1 (en) * 2005-10-21 2007-04-26 University Of Saskatchewan Oligoheteroaromatic luminiscent assemblies as high-affinity dna sequence-directed ligands
WO2007103584A2 (en) 2006-03-09 2007-09-13 Nanovir, Llc Polyamides for treating human papilloma virus
US8993609B2 (en) 2006-05-04 2015-03-31 Nanovir, Llc Compounds for treating papilloma virus infection
EP2013200B1 (en) 2006-05-04 2012-04-25 Nanovir, LLC Polyamides for treating human papilloma virus

Also Published As

Publication number Publication date
RU2014113702A (ru) 2015-11-20
CA2851516A1 (en) 2013-04-18
JP2015502330A (ja) 2015-01-22
SG11201401226YA (en) 2014-05-29
EP2751096A4 (en) 2015-04-08
WO2013055825A2 (en) 2013-04-18
HK1201064A1 (en) 2015-08-21
CN104024247A (zh) 2014-09-03
CN104024247B (zh) 2016-05-25
KR20140074996A (ko) 2014-06-18
NZ623292A (en) 2016-02-26
WO2013055825A3 (en) 2013-06-13
US20130090362A1 (en) 2013-04-11
CA2851516C (en) 2016-08-02
US9133228B2 (en) 2015-09-15
AU2012322835A1 (en) 2014-04-17
EP2751096A2 (en) 2014-07-09

Similar Documents

Publication Publication Date Title
UA118010C2 (uk) Інгібітори реплікації вірусів грипу
MY173422A (en) Purine derivatives for the treatment of viral infections
PH12015501678A1 (en) Inhibitors of influenza viruses replication
EA201491548A1 (ru) 2'-замещенные карбануклеозидные аналоги для противовирусного лечения
EA201791850A1 (ru) Борсодержащие малые молекулы
MY169159A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
MX2013006846A (es) Inhibidores de la replicacion de los virus de la influenza.
UA109650C2 (xx) Біс-арилзв'язані арилтриазолони та їх застосування
BR112013020042A2 (pt) inibidores de vírus da hepatite c
BR112012010270A2 (pt) mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco
BR112013028679A2 (pt) inibidores do vírus da hepatite c
EP2555798A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING HIV TRANSMISSIONS
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
JO3281B1 (ar) مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي
DOP2014000263A (es) Métodos de quelatos de oligonucleótidos
MX363270B (es) Composiciones y metodos para inhibir la polimerasa viral.
BR112013024974A2 (pt) composto, composição farmacêutica, método para o tratamento de infecções virais, e, processo para preparar um composto
PH12019502376A1 (en) Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
EP2865668A3 (en) Inhibitors and methods of inhibiting bacterial and viral pathogens
BR112014008464A2 (pt) composto; composição farmacêutica; método para ligar dna de fita dupla com especificidade para sequência; método para reduzir ou inibir a proliferação de células de papiloma ou neoplásticas; método para tratar células infectadas por vírus; e método para tratar hpv em um indivíduo
EA201490963A1 (ru) Новые производные гемина с антибактериальной и противовирусной активностью
WO2010128016A3 (en) Par2 agonists for use in the treatment or prevention of influenza virus type a infections
EA201691083A1 (ru) Ингибиторы репликации вирусов гриппа
UA111703C2 (uk) Інгібітори реплікації вірусів грипу
CO6290680A2 (es) Inhibidores de virus de la hepatitis c

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)